Ghantous Andre E, Ferneini Elie M
Division of Cardiology, Department of Medicine, Yale University School of Medicine, 333 Cedar St., New Haven, CT 06510, USA.
Private Practice, Greater Waterbury OMS, 435 Highland Avenue, Suite 100, Cheshire, CT 06410, USA; Beau Visage Med Spa, 435 Highland Avenue, Suite 100, Cheshire, CT 06410, USA; Division of Oral and Maxillofacial Surgery, Department of Craniofacial Sciences, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, USA.
Oral Maxillofac Surg Clin North Am. 2016 Nov;28(4):497-506. doi: 10.1016/j.coms.2016.06.003. Epub 2016 Aug 29.
Most patients with coronary artery disease and peripheral vascular disease are on long-term antiplatelet therapy and dual therapy. Achieving a balance between ischemic and bleeding risk remains an important factor in managing patients on antiplatelet therapy. For most outpatient surgical procedures, maintenance and continuation of this therapy are recommended. Consultation with the patient's cardiologist, physician, and/or vascular surgeon is always recommended before interrupting or withholding this treatment modality.
